CDK2 is strongly associated with proliferation in specific cancer types [35,36], and since CDK2 binds to cell cycle protein E to promote cell cycle progression, targeting CDK2 may offer new options for the treatment of these human cancers. The gene discussed is CDK2; the disease is cancer.